20-58909737-C-T
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PM5PP2PP3PP5_Very_Strong
The NM_000516.7(GNAS):c.772C>T(p.Arg258Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R258Q) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000516.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GNAS | ENST00000371085.8 | c.772C>T | p.Arg258Trp | missense_variant | 10/13 | 1 | NM_000516.7 | ENSP00000360126.3 | ||
GNAS | ENST00000676826.2 | c.2704C>T | p.Arg902Trp | missense_variant | 10/13 | ENSP00000504675.2 | ||||
GNAS | ENST00000371102.8 | c.2659C>T | p.Arg887Trp | missense_variant | 9/12 | 5 | ENSP00000360143.4 | |||
GNAS | ENST00000354359.12 | c.775C>T | p.Arg259Trp | missense_variant | 10/13 | 1 | ENSP00000346328.7 | |||
GNAS | ENST00000371095.7 | c.730C>T | p.Arg244Trp | missense_variant | 9/12 | 1 | ENSP00000360136.3 | |||
GNAS | ENST00000470512.6 | c.598C>T | p.Arg200Trp | missense_variant | 10/13 | 5 | ENSP00000499552.2 | |||
GNAS | ENST00000480232.6 | c.598C>T | p.Arg200Trp | missense_variant | 11/14 | 5 | ENSP00000499545.2 | |||
GNAS | ENST00000663479.2 | c.598C>T | p.Arg200Trp | missense_variant | 10/13 | ENSP00000499353.2 | ||||
GNAS | ENST00000462499.6 | c.553C>T | p.Arg185Trp | missense_variant | 9/12 | 2 | ENSP00000499758.2 | |||
GNAS | ENST00000467227.6 | c.553C>T | p.Arg185Trp | missense_variant | 10/13 | 3 | ENSP00000499681.2 | |||
GNAS | ENST00000478585.6 | c.553C>T | p.Arg185Trp | missense_variant | 9/12 | 2 | ENSP00000499762.2 | |||
GNAS | ENST00000481039.6 | c.553C>T | p.Arg185Trp | missense_variant | 9/12 | 5 | ENSP00000499767.2 | |||
GNAS | ENST00000485673.6 | c.553C>T | p.Arg185Trp | missense_variant | 9/12 | 5 | ENSP00000499334.2 | |||
GNAS | ENST00000488546.6 | c.553C>T | p.Arg185Trp | missense_variant | 9/12 | 5 | ENSP00000499332.2 | |||
GNAS | ENST00000492907.6 | c.553C>T | p.Arg185Trp | missense_variant | 9/12 | 3 | ENSP00000499443.2 | |||
GNAS | ENST00000371075.7 | c.*678C>T | 3_prime_UTR_variant | 10/13 | 1 | NM_016592.5 | ENSP00000360115.3 | |||
GNAS | ENST00000453292.7 | c.*633C>T | 3_prime_UTR_variant | 9/12 | 5 | ENSP00000392000.2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not provided Pathogenic:3Uncertain:1
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2023 | GNAS: PM2, PM5, PS4:Moderate, PM6:Supporting, PP2, PP3, PS3:Supporting - |
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Sep 22, 2023 | Published functional studies demonstrate a damaging effect as R258W causes a specific defect in activation (PMID: 9727013); Not observed in large population cohorts (gnomAD); This variant is associated with the following publications: (PMID: 9727013, 28708303, 31886927, 36835474, 27535533, 34614324) - |
Uncertain significance, flagged submission | clinical testing | Eurofins Ntd Llc (ga) | Nov 09, 2016 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 17, 2023 | This variant is also known as c.775C>T (p.Arg259Trp). This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 258 of the GNAS protein (p.Arg258Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with clinical features of GNAS-related conditions (PMID: 28708303, 31886927, 34614324). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 15941). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt GNAS protein function. Experimental studies have shown that this missense change affects GNAS function (PMID: 9727013, 34614324). This variant disrupts the p.Arg258 amino acid residue in GNAS. Other variant(s) that disrupt this residue have been observed in individuals with GNAS-related conditions (PMID: 29095814, 34614324), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. - |
Pseudohypoparathyroidism type I A Pathogenic:2
Pathogenic, criteria provided, single submitter | research | Genetics of Obesity Study, University of Cambridge | Jun 01, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | Sep 01, 2022 | The variant is not observed in the gnomAD v2.1.1 dataset. Missense changes are a common disease-causing mechanism. In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.69; 3Cnet: 0.54). Same nucleotide change resulting in same amino acid change has been previously reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000015941). A different missense change at the same codon (p.Arg258Gln) has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000453009). Therefore, this variant is classified as Pathogenic according to the recommendation of ACMG/AMP guideline. - |
Pseudopseudohypoparathyroidism Pathogenic:2
Pathogenic, no assertion criteria provided | literature only | OMIM | Sep 11, 1998 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Groupe Hospitalier Pitie Salpetriere, UF Genomique du Developpement, Assistance Publique Hopitaux de Paris | Jan 06, 2017 | Intellectual disability; small stature - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | May 17, 2018 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at